Impact of subcortical white matter lesions on dopamine transporter SPECT
- PMID: 23344720
- DOI: 10.1007/s00702-013-0977-1
Impact of subcortical white matter lesions on dopamine transporter SPECT
Abstract
Subcortical arteriosclerotic encephalopathy (SAE) can affect the nigrostriatal system and presumably cause vascular parkinsonism (VP). However, in patients with SAE, the differentiation of VP from idiopathic Parkinson's disease (IPS) is challenging. The aim of the present study was to examine the striatal dopamine transporter (DAT) density in patients with parkinsonism and SAE. Fifteen consecutive patients with parkinsonian symptoms displayed SAE, as detected by magnetic resonance imaging (MRI). Fifteen retrospectively chosen, matched patients with diagnosis of IPS without any abnormalities in MRI served as a reference group. DAT SPECT was performed using the tracer ¹²³I-FP-CIT. Scans were acquired on a triple-head SPECT system (Multispect 3, Siemens) and analysed using the investigator-independent BRASS™ software (HERMES). In the SAE group, a DAT deficit was observed in 9/15 patients. In contrast, all patients from the IPS group showed a reduced DAT binding (p = 0.008). The specific binding ratios (BR) of putamen contralateral to the side of the more affected limb versus occipital lobe were in trend higher in patients with SAE versus patients in the IPS-group (p = 0.053). Indices for putaminal asymmetry (p = 0.036) and asymmetry caudate-to-putamen (p = 0.026) as well as the ratio caudate-to-putamen (p = 0.048) were significantly higher in IPS patients having no SAE. DAT deficit was less pronounced in patients with SAE and parkinsonism than in patients with IPS without any abnormalities in the MRI. A potential role of DAT SPECT in the differential diagnosis of VP and IPS requires more assessments within prospective studies.
Similar articles
-
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1343-9. doi: 10.1007/s00259-008-0729-x. Epub 2008 Feb 19. Eur J Nucl Med Mol Imaging. 2008. PMID: 18283454
-
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.Nucl Med Commun. 2005 May;26(5):421-6. doi: 10.1097/00006231-200505000-00005. Nucl Med Commun. 2005. PMID: 15838424
-
Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.Neuroimage Clin. 2019;22:101755. doi: 10.1016/j.nicl.2019.101755. Epub 2019 Mar 12. Neuroimage Clin. 2019. PMID: 30884365 Free PMC article.
-
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.J Neurol. 2011 Dec;258(12):2147-54. doi: 10.1007/s00415-011-6076-z. Epub 2011 May 6. J Neurol. 2011. PMID: 21547379
-
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism.Neurology. 2025 Mar 11;104(5):e213352. doi: 10.1212/WNL.0000000000213352. Epub 2025 Feb 10. Neurology. 2025. PMID: 39928907
Cited by
-
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance.Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1333-1344. doi: 10.1007/s00259-023-06566-w. Epub 2023 Dec 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 38133688 Free PMC article.
-
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.Int J Mol Sci. 2021 Oct 18;22(20):11234. doi: 10.3390/ijms222011234. Int J Mol Sci. 2021. PMID: 34681899 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources